Research on film coating formulation of sustained release pellets of verapamil hydrochloride

Journal OF MILITARY PHARMACO - MEDICINE N04 - 2021  
RESEARCH ON FILM COATING FORMULATION OF SUSTAINED  
RELEASE PELLETS OF VERAPAMIL HYDROCHLORIDE  
Truong Duc Manh1, Vo Xuan Minh2, Phan Thi Hoa1  
Nguyen Van Bach1, Dinh Dinh Chinh3  
SUMMARY  
Objectives: To determine the optimized parameters of the technical process and the  
adequate excipient ingredients of the pellet film c oat which control release to develop the  
basic formula of the sustained release (SR) pellet of Verapamil hydrochloride (VER.HCl).  
Materials and method: Prepare SR VER.HCl pellet with film coating using Mini-Glatt  
fluidized bed; quantify VER.HCl with UV spectroscopy method; examine the effect of excipients  
(EC, HPMC, DBP, TEC and Talc) on the dissolution of SR VER.HCl pellet. Results: With  
excipients EC N20, HPMC E15, HPMC E5, TEC and Talc, the release rate of VER.HCl was  
9.02%, 26.55%, 48.90% and 83.73% at the time of 1, 2, 4 and 8 hours, respectively.  
Conclusion: EC N10, HPMC E15 and HPMC E5 controlled release excipients suitable for  
formula of SR VER.HCl pellet film 120 mg.  
* Keywords: Verapamil hydrochloride; Pellet; Sustained release; Preparation.  
INTRODUCTION  
frequency for patients, the study of SR  
VER.HCl pellet preparation is essential  
[4, 5]. In the formulation of SR VER.HCl  
pellet, controlled release film coating  
ingredients play a critical role, greatly  
influencing the rate and degree of  
pharmaceutical substance release from  
the drug form and drug bioavailability.  
Through this study, we aimed: To produce  
the results of investigating the effects of  
certain parameters of the technical process  
and controlled release film coating excipient  
as the basis for developing the basic  
formulation of SR VER.HCl pellet film  
120 mg.  
Verapamil hydrochloride (VER.HCl) is  
a calcium channel blocker used to treat  
angina pectoris, hypertension and  
arrhythmia. VER.HCl is completely  
absorbed in the gastrointestinal tract  
(about 90%), but the bioavailability is only  
20 - 35% due to its rapid metabolism  
through liver. This pharmaceutical  
substances have a short half - life  
(2.8 - 7.4 hours) causing patients to  
administer many times a day [1, 2, 3].  
Therefore,  
in  
order  
to  
improve  
bioavailability and reduce the dosing  
1Vietnam Military Medical University  
2Hanoi University of Pharmacy  
3Military Central Hospital 108  
Corresponding author: Truong Duc Manh (manhxn150@yahoo.com)  
Date received: 19/02/2021  
Date accepted: 26/4/2021  
143  
Journal OF MILITARY PHARMACO - MEDICINE N04 - 2021  
MATERIALS AND METHODS  
1. Materials and equipment  
Add plasticizer to the solution above, stir  
to homogenize. Crush talcum powder, sift  
through a 125 µm sieve. Add 96% ethanol  
and grind thoroughly, and pull gradually  
into the beaker containing coating solution.  
Stir the solution on a magnetic stirrer for  
about 30 minutes. Filter through a 125 µm  
sieve to obtain a homogeneous coating  
solution. Make up to the needed volume  
with 96% ethanol. The solution was  
stirred continuously on a magnetic stirrer  
throughout the coating process.  
*Materials and chemicals: VER.HCl  
Standard: Provided by Ho Chi Minh City  
Drug Quality Control Institute (QT242010914,  
concentration 100.52%), Pharmaceutical  
VER.HCl: USP 38 (China), HPMC E6,  
E15: USP 38 (China), Talc: USP 38 (China),  
EC N10, N20: USP 38 (China), DBP:  
USP 38 (India), TEC: USP 38 (China),  
Ethanol 96%: Vietnamese Pharmacopoeia IV.  
*Equipment and tools: Mini-Glatt film  
coating fluidized bed (Germany), Copley  
DIS 8000 dissolution tester (UK), Labomed  
UV-VIS spectrophotometer UVD-2960  
- Put pellets in the coating equipment:  
Dry pellets for about 15 minutes to heat  
up before spraying on the coating. Spray  
the coating solution. Keep spraying until  
(USA), analytical balance Mettler Toledo coating solution runs out, leave the  
equipment on for another 15 minutes.  
with readability down to 0.1 mg  
(Switzerland), PHARMATEST PTF  
E
Table 1: Parameters of the coating  
abrasion tester (Germany), ERWEKA  
SVM powder and granule tapped volume  
tester (Germany), ERWEKA GWF granular  
tester (Germany), sieve analysis (China)  
and other tools meeting laboratory and  
analytical testing standards.  
process.  
Spray pressure  
to be determined  
to be determined  
to be determined  
55 5°C  
Spray rate  
Fluidizing air volume  
Inlet air temperature  
Outlet air temperature  
Spray gun diameter  
42 1°C  
2. Methods  
1.2 mm  
*Preparation of VER.HCl controlled  
release pellets by pan coating technique:  
- The obtained pellets were dried at  
60°C for 6 hours and left overnight for the  
coating film to stabilize, then sifted to  
retain diameter of 0.8 - 1.5 mm.  
SR VER.HCl pellet was prepared by  
coating a release control film onto the  
core pellet which is  
a
composition  
- Film coating performance: calculated  
by the formula:  
including: EC (release control polymer),  
HPMC (creating diffusion channel), DBP,  
TEC (plasticizer), Talc (anti-sticking agent),  
96% ethanol (solvent). The process of  
coating release control film was carried  
out in steps as follows:  
m1m2  
Film-coating efficiency (%) =  
x 100%  
m3  
Of which: m1: Total weight of pellet  
after coating (g);  
m2: Weight of core pellet before  
coating (g);  
- Prepare coating solution: Soak and  
dissolve completely EC in approximately  
2/3 of 96% ethanol, add HPMC to dissolve.  
m3: Weight of solids in the formula of  
film coat (g).  
144  
Journal OF MILITARY PHARMACO - MEDICINE N04 - 2021  
* Drug content:  
+ Equipment: Stirrer.  
- Test sample: Weigh approximately 2g  
of pellet, grind into fine powder. Precisely  
weigh the corresponding amount of fine  
powder to roughly 50 mg of VER.HCl.  
Transfer to a 50 mL beaker. Add  
approximately 30 mL of pH 7.5 phosphate  
buffer solution. Shake in ultrasonic shaker  
for 60 mins. Transfer to a 50 mL  
volumetric flask, add phosphate buffer of  
pH 7.5 to the mark and mix well. Filter  
through a filter paper, discard roughly 10  
mL of the primary filtrate, the remaining  
filtrate was solution A. Pipette 0.5 mL of  
solution A into a 10 mL volumetric flask,  
make up to the mark with pH 7.5 phosphate  
buffer solution and mix. Read the solution  
in spectrophotometer at a wavelength  
λ = 278 nm. Simultaneously carry out the  
same procedure with the standard solution  
under the same conditions. The content  
of pharmaceutical substances in pellet  
was calculated by the following formula:  
+ Stirring speed: 50 2 rpm.  
+ Temperature: 37.0 0.5°C.  
+ Medium: 900 mL of phosphate buffer  
solution of pH 7.5.  
+ Sampling time: At interval of 1, 2, 4  
and 8 hours.  
+ Test sample: Pellet quantity equivalent  
to 120 mg VER.HCl  
+ Quantify pharmaceutical substances  
released at sampling times by measuring  
the absorbance at a wavelength of 278 nm.  
Calculate the amount of pharmaceutical  
substances release based on the reference  
point of VER.HCl in pH 7.5 phosphate  
buffer medium using UV-VIS spectroscopy  
method.  
RESULTS AND DISSCUSION  
1. Results of investigation of the  
effects of certain parameters in the  
technical procedure  
In order to determine the adequate film  
coating parameters, fundamental pellet  
film formula includes: Core pellets of  
VER.HCl: 20.00g; EC N10: 3.00g; DEP:  
0.24 g; Talc powder: 1.50g; Ethanol 96%:  
50 mL.  
At.mc  
% VER.HCl ⁄pellet=  
x 100 (%)  
Ac.mt  
Of which: At: Optical density of sample  
solution;  
Ac: Optical density of standard solution;  
mc: Weight of VER.HCl standard weight  
- Effects of coating solution spray rate:  
to quantify;  
The coating solution spray rate varied  
at 0.45 mL/min; 0.85 mL/min and 1.25  
mL/min. Core pellet of VER.HCl was  
overcoated with coating parameters and  
the results were shown as below:  
mt: Weight of pellet to quantify.  
* In vitro dissolution studies:  
Testing conditions: complied to USP 41 [5]  
under the following specific conditions:  
145  
Journal OF MILITARY PHARMACO - MEDICINE N04 - 2021  
Table 1: Results of effects of coating solution spray rate on the coating process.  
No.  
1
Parameters  
Fluidizing air volume (m3/hour)  
Spray pressure (bar)  
Inlet air temp (°C)  
Value  
18  
2
1.2  
3
55  
42  
5
1
4
Outlet air temp (°C)  
5
Spray gun diameter (mm)  
Spray rate (mL/min)  
1.2  
6
0.45  
0.85  
1.25  
-
Coating efficiency (%)  
60.76  
73.21  
Results  
Uniform coat, stabilized pellet Pellet agglutination  
fluidizing  
Physical properties  
Spray rate increasing from 0.85 to 1.25 mL/min resulted in pellet agglutination.  
Whereas spray rate at 0.45 and 0.85 mL/min led to stabilized coating fluidizing results.  
However, the coating efficiency at 0.45 mL/min was lower due to slower spray rate and  
fast evaporation rate of the coating solution solvent. Therefore, spray rate of 0.85 mL/min  
was selected in the next studies to increase optimization.  
- Effects of spray pressure:  
In order to determine the optimized spray pressure, various spray pressures were  
used while other parameters were kept constant: Fluidizing air volume: 18 m3/hour,  
spray rate: 0.85 mL/min, inlet air temp: 55 5°C, outlet air temp: 42 1°C, spray gun  
diameter: 1.2 mm. The testing parameters used to determine spray pressure and their  
results are demonstrated in table 2.  
Table 2: Results of effects of spray pressure on the coating process.  
Parameters  
Spray pressure (bar)  
Results  
Value  
1.0  
1.2  
1.4  
Coating efficiency (%)  
-
73.21  
67.30  
Uniform coat, stabilized  
pellet fluidizing  
Physical properties  
Pellet agglutination  
Pellet pulverization  
Low spray pressure (1.0 bar) increased spray droplet sizes, reduced evaporation  
rate and enhanced pellet agglutination. In contrast, higher spray pressure (1.4 bar)  
caused pellet pulverizations, reduced spray droplet sizes, enhanced evaporation rate,  
altogether resulting in efficiency loss. The technical specifications of equipment greatly  
affected coating performance as well as the quality of the pellet film. Therefore, spray  
pressure of 1.2 bar was selected to be used in the next studies.  
146  
Journal OF MILITARY PHARMACO - MEDICINE N04 - 2021  
- Effects of fluidizing air volume:  
In order to determine the optimized fluidizing air volume, various fluidizing air  
volumes were used while other parameters were kept constant: spray pressure: 1.2 bar,  
spray rate: 0.85 ml/min, inlet air temp: 55 5°C, outlet air temp: 42 1°C, spray gun  
diameter: 1.2 mm. The testing parameters and results are shown in table 3.  
Table 3: Results of effects of fluidizing air volume.  
Parameters  
Fluidizing air volume (m3/hour)  
Results  
Value  
12  
18  
24  
Coating efficiency (%)  
36.50  
73.21  
43.88  
Ununiformed coat, poor Stabilized pellet Ununiformed coat, strong  
pellet fluidizing fluidizing attrition, strong fluidizing  
Physical properties  
Fluidizing air volume of 12 m3/hour reduced coating efficiency (36.50%) and  
ununiformed coating surface due to poor fluidizing which caused pellet core to take on  
the next layer of coating solution before the previous one fully evaporated. On the other  
hand, poor fluidizing also caused pellets fail to take on the full coating solution volume.  
Fluidizing air volume of 24 m3/hour also gave a low efficiency (43.88%). Due to strong  
fluidizing, pellets collided with the film sides in which ununiformed pellet surface  
resulting from pellets unable to fully take on thecoating solution volume. Also, the solvent  
evaporated quickly left the pellet surface dry. Fluidizing air volume of 18 m3/hour  
produced the highest efficiency (73.21%), the surface was smooth, uniform and stable.  
Subsequently, fluidizing air volume of 18 m3/hour was selected.  
From the testing results, the following coating parameters are selected:  
Spray pressure: 1.2 bar; spray rate: 0.85 mL/min; ni let air temperature: 55 5°C; outlet  
3
air temperature: 42 1°C; spray gun diameter: 1.2mm; fluidizing air volume: 18 m /hour.  
2. Results of determining the effects of the release control film formulation  
- Effects of proportion and type of release control polymer:  
Screening studies have found that different proportions of pellet film ingredients  
changed the rate of pharmaceutical substance release from pellets. The formulations  
designed to determine the effects of the EC proportion were presented in table 4.  
Table 4: The formulations designed to determine the optimized EC proportion.  
Formulations  
Ingredients  
F1  
F2  
F3  
F4  
F5  
-
F6  
-
EC N10 (g)  
3
4
5
-
EC N20 (g)  
-
-
-
3
4
5
DBP (% w/w EC)  
Talc (% w/w EC)  
EtOH 96% (mL)  
6
6
6
6
6
6
50  
50  
50  
50  
50  
50  
50  
50  
50  
50  
50  
50  
Prepare coating solution and carry out coating each batch of 20g core pellets of VER.HCl.  
Testing results of the film forming polymer concentration were shown in table 5 and figure 1.  
147  
Journal OF MILITARY PHARMACO - MEDICINE N04 - 2021  
Table 5: Release rate of VER.HCl during EC proportion testing (n = 6;  
SD)  
Release rate of VER.HCl over time (hour)  
Formulations  
1
2
4
8
CT1  
CT2  
42.08 1.04  
21.65 1.13  
17.42 0.76  
6.91 0.12  
6.11 0.05  
5.67 0.02  
2 - 12  
72.74 1.66  
47.43 1.12  
31.70 0.90  
8.95 0.43  
7.18 0.10  
5.68 0.02  
10 - 25  
86.84 1.03  
67.92 1.98  
61.20 1.40  
18.83 0.82  
11.07 0.37  
5.82 0.05  
25 - 50  
101.19 1.53  
95.21 1.97  
83.29 3.35  
29.76 1.05  
13.32 0.75  
6.15 0.07  
> 80  
CT3  
CT4  
CT5  
CT6  
USP 41 (%)  
CT1  
CT4  
CT2  
CT5  
CT3  
CT6  
120  
100  
80  
60  
40  
20  
0
0
1
2
3
4
5
6
7
8
9
Time (hour)  
Figure 1: The release rate of VER.HCl over time during EC proportion testing.  
Increased proportion of both types of EC in the film ingredients reduced the release  
rate of VER.HCl as when the EC proportion increases, the pellet film thickness also  
increases, thereby increasing the diffusion distance leading to a decrease in the  
release rate of pharmaceutical substance to the dissolved medium. With EC N10 film  
forming polymer, all three formulations yielded higher rate of pharmaceutical substance  
release than criteria in USP41. Particularly, at 1 hour, all three formulations CT1, CT2  
and CT3 showed the release rate of pharmaceutical substance higher than 12%.  
4 hours later, it exceeded 50% and these formulations were almost completely  
released 8 hours later. The formulation using 5g of EC (CT3 and CT6), the coating had  
some difficulties due to the increased viscosity of the film-forming suspension resulting  
in pellet agglutination. Thus, EC N10 is not adequate to be used as an ingredient of  
release control VER.HCl pellet film. Replace EC N10 with EC N20, all three  
formulations adequately controlled rate of pharmaceutical substance release. CT5 and  
CT6 gave the lowest rate of drug release due to great film thickness which prevented  
VER.HCl from diffusing into the dissolved medium. After 8 hours, both CT5 and CT6  
yielded rate lower than 15%. CT4 using 3g of EC N20 was capable of controlling  
pharmaceutical substance release. As a result, CT4 was selected for the next studies.  
148  
Journal OF MILITARY PHARMACO - MEDICINE N04 - 2021  
- Effects of the proportion and type of polymer combination:  
As CT4 gave a relatively small rate of pharmaceutical substance release compared  
to what was required by USP 41, it was necessary to increase the rate of pharmaceutical  
substance release by combining some hydrophilic polymers to create diffusion  
channels on the pellet film to enhance the rate. Based on the formulations designed as  
in table 6, the dissolution is evaluated and presented as results in table 7 and figure 2.  
Table 6: Formulations designed to determine the optimized proportion of polymer  
combination.  
Formulations  
Ingredients  
CT4  
CT7  
CT8  
CT9  
CT10  
3
CT11  
3
CT12  
3
EC N20 (g)  
3
3
3
3
HPMC E6 (% w/w EC)  
HPMC E15 (% w/w EC)  
DBP (% w/w EC)  
Talc (% w/w EC)  
EtOH 96% (mL)  
0
15.0  
0
17.5  
0
20.0  
0
0
0
0
0
15.0  
6
17.5  
6
20.0  
6
6
6
6
6
50  
50  
50  
50  
50  
50  
50  
50  
50  
50  
50  
50  
50  
50  
Table 7: Released rate of VER.HCl during polymer combination proportion testing  
(n = 6;  
SD).  
Rate of VER. HCl released over time (hour)  
Formulations  
1
2
4
8
CT4  
CT7  
6.91 0.12  
7.44 0.13  
16.95 0.85  
30.06 0.90  
7.21 0.36  
8.02 0.11  
18.02 0.58  
2-12  
8.95 0.43  
17.89 0.83  
35.93 0.97  
50.12 1.56  
8.73 0.13  
19.93 0.89  
28.88 1.15  
10-25  
18.83 0.82  
38.67 1.16  
83.77 2.16  
91.27 4.21  
16.68 0.79  
40.23 0.81  
55.03 1.49  
25-50  
29.76 1.05  
66.74 1.38  
93.54 2.16  
98.66 3.97  
27.24 1.06  
70.30 2.52  
84.34 2.61  
> 80  
CT8  
CT9  
CT10  
CT11  
CT12  
USP 41 (%)  
120  
100  
80  
CT4  
CT10  
CT7  
CT8  
CT9  
CT11  
CT12  
60  
40  
20  
0
0
1
2
3
4
5
6
7
8
9
Time (hour)  
Figure 2: The release rate of VER.HCl over time during polymer combination proportion testing.  
149  
Journal OF MILITARY PHARMACO - MEDICINE N04 - 2021  
Increased amount of HPMC E6 and E15  
enhanced the release rate of pharmaceutical proportion:  
substance of the formulation due to an  
- Effects of HPMC E6 and HPMC E15  
Based on HPMC type testing, it was  
increase in the number of pharmaceutical  
substance diffusion channels. The results  
showed that all six formulations increased  
the release rate of pharmaceutical  
substance compared to F4. With both  
types of HPMC used at low levels (CT7  
and CT10), the rate after 8 hours of  
release was lower than 70% as compared  
to high levels (20%), the release rate of the  
formulation exceeded the requirement by  
USP 41. With two types of polymers,  
HPMC E15 controlled release better than  
E5 due to its higher viscosity. Based on  
the obtained results above, CT11 was  
selected (HPMC E15 = 17.5% compared  
to EC) to be used in the next studies.  
found that HPMC E5 with lower viscosity  
would give higher rate of pharmaceutical  
substance release in the first hours while  
HPMC E15 with higher viscosity would  
corrode and swell more slowly enabling it  
to control pharmaceutical substance release  
in hours that follow. Therefore, it is  
necessary to select the combination of  
these two polymers to be used in pellet  
film ingredients. However, since HPMC  
has poorer solubility in ethanol than water,  
an additional 5 mL of distilled water should  
be used to dissolve HPMC. Based on the  
formulations designed as in table 8, the  
dissolution was evaluated and presented  
as results in table 9 and figure 3.  
Table 8: Formulations designed to determine the optimized HPMC E6 and HPMC  
E15 combination proportion.  
Formulations  
Ingredients  
CT11  
CT13  
CT14  
3
CT15  
3
EC N20 (g)  
3
3
HPMC E6 (% w/w EC)  
HPMC E15 (% w/w EC)  
DBP (% w/w EC)  
Talc (% w/w EC)  
Distilled water (mL)  
EtOH 96% (mL)  
0
2.5  
15.0  
6
5.0  
12.5  
6
7.5  
10.0  
6
17.5  
6
50  
5
50  
5
50  
5
50  
5
50  
50  
50  
50  
Table 9: The release rate of VER.HCl during HPMC E6 and HPMC E15 combination  
proportion testing (n = 6;  
SD).  
Release rate of VER. HCl over time (hour)  
Formulations  
1
2
4
8
CT11  
CT13  
8.02 0.11  
9.31 0.45  
13.65 0.54  
21.47 0.98  
2 - 12  
19.93 0.89  
26.62 0.82  
30.06 2.21  
42.33 1.29  
10 - 25  
40.23 0.81  
52.12 1.19  
56.81 0.59  
65.09 1.44  
25 - 50  
70.30 2.52  
83.21 2.70  
89.30 3.50  
96.84 3.34  
> 80  
CT14  
CT15  
USP 41 (%)  
150  
Journal OF MILITARY PHARMACO - MEDICINE N04 - 2021  
120  
100  
80  
60  
40  
20  
0
CT11  
CT14  
CT13  
CT15  
0
1
2
3
4
5
6
7
8
9
Time (hour)  
Figure 3: The release rate of VER. HCl over time during HPMC E6 and  
HPMC E15 combination proportion testing.  
Reduced HPMC E15/HPMC E6 increased the release rate of pharmaceutical  
substance of all formulations due to an increase in the weight of HPMC E5 in the  
polymer mixture. The results showed that all three formulations increased the rate  
compared to CT11 (without HPMC E5). CT14 and CT15 (using HPMC E5 at 5% and  
7.5%) which yielded higher release rate of pharmaceutical substance in the first hours  
due to low viscosity accounted for a large proportion in the combined polymer mixture.  
They absorbed water and dissolved quickly creating porous diffusion in pellet film, thus  
released more pharmaceutical substances than CT13 (HPMC E15 = 2.5% compared to  
EC). Based on the findings above, CT13 (HPMC E15 = 2.5% compared to EC) was  
selected to be used in the next study.  
- Effects of plasticizer:  
Testing with two plasticizers, DBP and TEC were conducted. Based on the  
formulations designed as in table 10, the dissolution was evaluated and presented as  
results in table 11 and figure 4.  
Table 10: Formulations designed to determine the optimized plasticizer.  
Formulations  
Ingredients  
CT13  
CT16  
CT17  
CT18  
CT19  
CT20  
EC N20 (g)  
3
3
3
3
3
3
HPMC E6 (% w/w EC)  
HPMC E15 (% w/w EC)  
2.5  
2.5  
2.5  
2.5  
2.5  
2.5  
15.0  
15.0  
15.0  
15.0  
15.0  
15.0  
DBP (% w/w EC)  
TEC (% w/w EC)  
Talc (% w/w EC)  
Distilled water (mL)  
EtOH 96% (mL)  
6
-
8
-
10  
-
-
-
-
6
8
10  
50  
5
50  
5
50  
5
50  
5
50  
5
50  
5
50  
50  
50  
50  
50  
50  
151  
Journal OF MILITARY PHARMACO - MEDICINE N04 - 2021  
Table 11: Release rate of VER.HCl during plasticizer testing (n = 6;  
SD).  
Release rate % of VER. HCl over time (hour)  
Formulations  
1
2
4
8
CT13  
CT16  
9.31 0.45  
8.99 0.14  
8.58 0.42  
10.45 0.36  
12.71 0.43  
18.31 0.85  
2 - 12  
26.62 0.82  
19.31 0.59  
17.71 0.88  
30.51 1.28  
30.09 1.23  
39.29 1.53  
10 - 25  
52.12 1.19  
42.16 1.34  
39.56 1.27  
50.04 1.70  
55.04 1.93  
58.75 1.68  
25 - 50  
83.21 2.70  
76.11 1.84  
69.35 2.97  
86.56 3.88  
90.49 3.60  
97.09 4.32  
> 80  
CT17  
CT18  
CT19  
CT20  
USP 41 (%)  
120  
100  
80  
CT13  
CT18  
CT16  
CT19  
CT17  
CT20  
60  
40  
20  
0
0
1
2
3
4
5
6
7
8
9
Time (hour)  
Figure 4: Release rate (%) of VER. HCl over time during plasticizer testing.  
Increased proportion of DEP in pellet film formulations would reduce film  
permeability as DEP, a known hydrophobic plasticizer, lower pharmaceutical  
substance release rate. Specifically: CT16 and CT17 with large DEP proportions  
reduced pharmaceutical substance release rate more clearly than CT13. These two  
formulations released less than 80% pharmaceutical substance after 8 hours. In the  
case of TEC plasticizer, a hydrophilic plasticizer, higher proportion of TEC would result  
in higher rate of pharmaceutical substance release. During the preparation process,  
DBP was also found to be difficult to dissolve in 96% ethanol, the coating solution  
easily formed a sheen on the surface. It was difficult for DBP to disperse to uniformly  
plasticize the film surface. Based on the findings above and to be in line with the USP  
41 standard on solubility, CT18 with TEC proportion of 6% of EC weight is selected to  
be used in the next study.  
152  
Journal OF MILITARY PHARMACO - MEDICINE N04 - 2021  
- Effect of anti-sticking agent:  
Testing out formulations with different talc proportions as shown in table 12 and  
coating on 20g pellets with 50 mL of coating solution containing approximately 10%  
solids with similar coating performance. Dissolution evaluation results are shown in  
table 13 and figure 5.  
Table 12: Formulations designed to determine the optimized anti-sticking agent.  
Formulations  
Ingredients  
CT18  
CT21  
CT22  
CT23  
3
EC N20 (g)  
3
3
3
HPMC E6 (% w/w EC)  
HPMC E15 (% w/w EC)  
Talc (% w/w EC)  
TEC (% w/w EC)  
Distilled water (mL)  
96% EtOH (mL)  
2.5  
15.0  
50  
6
2.5  
15.0  
60  
6
2.5  
15.0  
40  
6
2.5  
15.0  
30  
6
5
5
5
5
50  
50  
50  
50  
Table 13: Release rate of VER.HCl during anti-sticking agenttesting (n = 6;  
SD).  
Release rate % of VER. HCl over time (hour)  
Formulations  
1
2
4
8
CT18  
CT21  
10.45 0.36  
22.90 1.02  
9.02 0.14  
32.65 1.24  
2 - 12  
30.51 1.28  
46.90 2.03  
26.55 1.20  
60.11 1.65  
10 - 25  
50.04 1.70  
79.54 3.09  
48.90 1.42  
90.59 3.37  
25 - 50  
86.56 3.88  
97.33 3.69  
83.73 2.70  
98.18 4.09  
> 80  
CT22  
CT23  
USP 41 (%)  
120  
100  
80  
CT18  
CT22  
CT21  
CT23  
60  
40  
20  
0
0
1
2
3
4
5
6
7
8
9
Time (hour)  
Figure 5: The rate of VER. HCl released over time during anti-sticking agent testing.  
153  
Journal OF MILITARY PHARMACO - MEDICINE N04 - 2021  
With a small talc proportion (30%), the pellet fluidizing was stable, uniform and  
release rate of pharmaceutical substance smooth surface finish was achieved.  
obtained was more than 30%. The cause  
- Having selected release control  
may be due to the insufficient amount of  
excipients EC N20 as well as two  
talc which failed to prevent agglutination  
hydrophilic polymers, HPMC E15/E6,  
during the coating process, ultimately  
to create diffusion channels, from which  
causing agglutination and puncture in pellet  
the pellet film formulation is formulated  
films. As for the large talc proportion (60%),  
consisting of: EC N20, HPMC E6, HPMC E15,  
high rate of pharmaceutical substance  
Talc, TEC, distilled water and EtOH 96%.  
release was also obtained (22.9% after  
1 hour) for which the reason was that an  
REFERENCES  
excessive amount of talc powder led to  
1. Ministry of Health. Vietnamese National  
unstable and cracked films when  
Drug Formulary. Medical Publishing House  
measuring solubility. CT18 and CT22  
2015.  
have similar solubility curves, the less the  
2. Anthony CM, et al. Clarke’ s analysis of  
amount of talc, the slower pharmaceutical  
drugs and poisons. Pharmaceutical Press.  
substance is to release. It was observed  
London 2011: 2223-2224.  
that CT22 released more slowly and gave  
3. Sweetman SC, et al. Martindale 36th,  
the release rate of pharmaceutical  
RPS Publishing 2009:1522-1526.  
substance at all hours closer to what is  
4. Nitin DJ, Dipak DG, Ashish AH, et al.  
stipulated by USP 41.  
Formulation development and evaluation of  
sustained release pellets of verapamil HCl.  
CONCLUSIONS  
International Journal of Pharma Research and  
- Having determined the effects of  
Development 2010; 1(11):1-7.  
certain parameters of the technical film  
5. Vidyadhara S, Prasad MB, Sasidhar  
coating process to control the release of  
RLC, et al. Development and evaluation of  
core pellet of VER.HCl. With parameters  
controlled release verapamil hydrochloride  
such as: Spray pressure: 1.2 bar, spray  
pellets by pan coating process. Current  
rate: 0.85 mL/min, fluidizing air volume:  
18 m3/hour, inlet air temperature: 55 5°C,  
Trends in Biotechnology and Pharmacy 2013;  
7(1):535-543.  
outlet air temperature: 42  
1°C, spray  
6. USP 41-NF 36. Monographs: Verapamil  
hydrochlorid extended-release tablets 2018;  
4307-4311.  
gun diameter: 1.2 mm, the coating process  
gave a high efficiency (73.21%) in which  
154  
pdf 12 trang yennguyen 15/04/2022 1880
Bạn đang xem tài liệu "Research on film coating formulation of sustained release pellets of verapamil hydrochloride", để tải tài liệu gốc về máy hãy click vào nút Download ở trên

File đính kèm:

  • pdfresearch_on_film_coating_formulation_of_sustained_release_pe.pdf